Patents by Inventor Peter Bühlmayer

Peter Bühlmayer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Valsartan salts
    Patent number: 8278339
    Abstract: The invention relates to new salts of valsartan or crystalline, also partly crystalline and amorphous salts of valsartan, the respective production and usage, and pharmaceutical preparations containing such a salt.
    Type: Grant
    Filed: August 5, 2008
    Date of Patent: October 2, 2012
    Assignee: Novartis AG
    Inventors: Erwin Marti, Hans R Oswald, Peter Bühlmayer, Wolfgang Marterer
  • Selective NPY (Y5) antagonists (tricyclics)
    Patent number: 6222040
    Abstract: This invention is directed to tricyclic compounds which are selective antagonists for NPY (Y5) receptors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of the compound of this invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: June 30, 1999
    Date of Patent: April 24, 2001
    Assignee: Synaptic Pharmaceutical Corporation
    Inventors: Mohammad R. Marzabadi, Peter Bühlmayer, Heinrich Rüeger, Wai C. Wong, Yasuchika Yamaguchi, Stewart A. Noble